CD8A and COVID-19: Emerging evidence demonstrated that COVID-19 vaccination in the ipsilateral arm was immunogenically superior to the contralateral arm vaccination in the neutralizing activity of anti-S IgG, median spike-specific CD8 T-cell levels, and CTLA-4 expression on spike-specific CD4 T-cells [54].